Form D · Biotechnology
Envoy Therapeutics, Inc.
Boca Raton, FL · CIK 0001472617
Offering snapshot reported Sep 18, 2009 · SEC filing
- Reported sold
- $519 Offering amount: $519
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 24, 2009 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 18, 2009 | Initial | $519 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-134563
Source: Form D, filed Sep 18, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Bradley A. Margus | Director, Executive |
| Robert Middlebrook | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
21645 Cartagena Drive
Boca Raton, FL, 33428
Boca Raton, FL, 33428